NASTAD’s National Ryan White HIV/AIDS Program (RWHAP) Part B and AIDS Drug Assistance Program (ADAP) Monitoring Project Report documents key trends, challenges, and successes faced by public health programs ensuring access to life-saving treatment and services for people living with HIV/AIDS (PLWHA) nationally. The 2021-2022 edition of the Report includes longitudinal data spanning several domains of the RWHAP Part B program and ADAP widely considered essential to the federal Ending the HIV Epidemic (EHE) initiative and potentially impacted by the novel coronavirus SARS-CoV-2 (COVID-19) pandemic.
This report differs somewhat from those previously released, in that we are providing data points spanning two calendar years – 2019 and 2020 – that we expected to be most dynamic due to EHE initiatives and COVID-19, including total RWHAP Part B and ADAP clients enrolled and served, client demographics, ADAP expenditures, and viral load suppression rates. Also included are abbreviated snapshots of additional calendar year (CY) 2019 program metrics and fiscal year (FY) 2020 budget details, including EHE awards and Coronavirus Aid, Relief and Economic Security (CARES) Act funding.
Unless otherwise noted, findings highlighted in this report are based on survey responses received from 46 states, the District of Columbia, and two U.S. territories (Puerto Rico and the U.S. Virgin Islands). Some of these jurisdictions noted their inability to complete this year’s full survey due to unprecedented COVID-19-related program capacity strains. No fiscal or programmatic data were received from Alabama, Indiana, Mississippi, or Nevada.